InvestorsHub Logo
Followers 21
Posts 1996
Boards Moderated 0
Alias Born 11/26/2014

Re: citoyen post# 3511

Friday, 04/26/2019 5:23:54 AM

Friday, April 26, 2019 5:23:54 AM

Post# of 4159
Enroll, Treat 2Q2019 - Company guidelines holding strong.


Health Canada Clinical Trial Authorization (“CTA”)Complete, Investigational Testing Authorization (“ITA”)Complete. Clinical Site Review Ethics Board (“REB”)Pending- Approval to Commence Enrolling and Treating Patients in Canada 2Q2019 Completed!!!
Theralase Commences Phase II NMIBC Clinical Study

FDA Investigational New Drug (“IND”) and European IND Approval to Commence Enrolling and Treating Patients in the United States and Europe 3Q2019

Enroll, Treat and Follow-Up Approximately 100 NMIBC Patients in Canada, the United States and Europe 2Q2019 to 4Q2021


http://theralase.com/wp-content/uploads/2019/03/Theralase-Corporate-Power-Point-Presentation-03-25-2019.pdf

JMO, maybe, maybe not.